Does blood pressure increase during opioid withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Blood Pressure Increases During Opioid Withdrawal

Blood pressure does increase when a patient is going through opioid withdrawal, along with other signs of sympathetic nervous system activation. This occurs because chronic opioid use suppresses norepinephrine release, and abrupt discontinuation leads to supranormal release of norepinephrine, producing autonomic hyperactivity 1.

Physiological Mechanism

Opioids acutely inhibit norepinephrine release at synaptic terminals. With chronic exposure, tolerance develops and norepinephrine release gradually increases toward normal levels. When opioids are suddenly stopped, this results in excessive norepinephrine release, manifesting as:

  • Hypertension (elevated systolic and diastolic blood pressure)
  • Tachycardia (increased heart rate)
  • Increased respiratory rate
  • Pupil dilation (mydriasis)
  • Diaphoresis
  • Piloerection 1, 2

Clinical Evidence

Research confirms these cardiovascular changes are substantial. In one study of naloxone-precipitated withdrawal in opioid-dependent patients, systolic blood pressure increased significantly (113 to 138 mmHg), heart rate rose from 89 to 108 beats/min, and epinephrine concentrations increased 30-fold 3. Another study documented significant increases in both systolic pressure and heart rate during naloxone-induced withdrawal 4.

The blood pressure elevation is part of a broader withdrawal syndrome characterized by "autonomic overreactivity" that includes the cardiovascular changes alongside CNS irritability and gastrointestinal dysfunction 5.

Clinical Implications for Management

Timing of Symptoms

  • Short-acting opioids (heroin, morphine): Symptoms begin 6-12 hours after last use, peak at 48-72 hours
  • Long-acting opioids (methadone): Onset up to 30 hours after last use 5

Treatment Approach

α2-adrenergic agonists specifically target the hypertension and tachycardia of withdrawal by directly counteracting the excessive sympathetic activity:

  • Clonidine or lofexidine are first-line agents for treating symptomatic patients with non-hypotensive opioid withdrawal 5
  • These medications suppress withdrawal symptoms but may cause orthostasis or hypotension, necessitating small initial doses and careful titration 6
  • Benzodiazepines can help reduce catecholamine release during withdrawal 5

Important Caveats

While the cardiovascular changes are uncomfortable and clinically significant, opioid withdrawal is rarely directly life-threatening as a sole condition 5. However, the elevated blood pressure and heart rate require monitoring and treatment, particularly in patients with underlying cardiovascular disease.

The use of α2-agonists should be reserved for "symptomatic patients with non-hypotensive opioid withdrawal" 5, emphasizing the need to check blood pressure before administration to avoid excessive hypotension.

Buprenorphine or methadone remain the most effective treatments for alleviating all withdrawal symptoms, including the cardiovascular manifestations, and should be considered over purely symptomatic management when appropriate 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.